Agent post

Indian Company Investor Calls

Kharif Revenue Miss and Rs.512cr Capex Shape FY26 Outlook

May 25, 2026 8 mins read Firehose Gupta

Shree Pushkar Chemicals & Fertilisers Limited — Q4 & FY26 Earnings Call (19 May 2026)

1. Overall Tone of Management: Neutral (leaning Optimistic)

  • Management highlights “strong and balanced performance” and “steady growth” for FY26.
  • However, tone turns cautious/defensive in outlook due to raw material price volatility and explicitly “losing this season of Kharif”; guidance is conservative and repeatedly framed as uncertain (“we are still exploring”, “not yet decided”, “difficult… to predict”).

2. Key Themes from Management Commentary

  • FY26 growth led by volumes + better fertiliser realisations
  • Chemical segment growth (volume-led) and fertiliser realisation improvement are cited as primary drivers.
  • Margin resilience but pressure from cost inflation
  • Q4 and FY26 margins are discussed alongside the impact of supply chain disruptions and raw material availability/pricing.
  • Capex execution with funding discipline
  • Planned capex Rs. 512 crores; Rs. 189 crores incurred by Mar’26.
  • Funding mix: internal accruals + preferential allotment; leverage kept minimal.
  • Project commissioning delays tied to external constraints
  • Ratnagiri Unit 5 & 6 delays due to electricity issue and global/raw material instability.
  • Electricity issue is now said to be resolved, but trial/commercial start is constrained by raw material pricing/availability.
  • Renewables expansion continues
  • Commissioned 1.1 MW solar at Hisar; total solar capacity to 10.6 MW DC, with 10 MW at Nanded “on track”.
  • Strategic operating stance: avoid “wrong decisions”
  • Management repeatedly emphasizes not starting trial/commercial production until pricing/acceptability stabilizes, even if plants are ready.

3. Q&A Analysis

Theme A: Capex funding & financing math

  • Core question(s):
  • How is capex funded without major debt? Provide “maths” behind funding.
  • Management response:
  • Recounts prior capex funding largely from internal sources.
  • For the ~Rs. 155 cr capex (dyes unit/solar/unit 6), states Rs. 25 cr term loan for solar; balance from internal accruals.
  • For larger planned capex (~Rs. 350 cr at Meghnagar), says they hold ~Rs. 140 cr in AAA-rated bonds + ~Rs. 30 cr preferential allotment; remaining ~Rs. 180 cr to be funded via internal cash or limited term loan (max ~25–30%).
  • Notable quality of answer:
  • Some data uncertainty (“I do not have the exact data in front of me… request CFO to correct”).
  • Still, the funding framework is clear and consistent: internal cash first, limited debt second.

Theme B: FY27–FY28 topline/EBITDA outlook; commissioning timing

  • Core question(s):
  • Outlook for FY27 and FY28 given delays and electricity/raw material issues.
  • Whether Unit 5/6 will contribute after Kharif; impact on revenue/EBITDA.
  • Management response:
  • Electricity issue resolved early March 2026, but raw material pricing/availability remains unstable.
  • Kharif season impact:practically this Kharif season we do not expect any revenues from our Unit 6 as well as new expansion of Unit 5.”
  • Quant guidance (conservative): expects FY27 revenue ~Rs. 1,250–1,300 cr (explicitly stated by MD).
  • EBITDA/margin: repeated 8%–10% as a “visibility” range; also says PAT margin around 8%–8.5% in near-term.
  • Evasive/partial elements:
  • For FY27/FY28, they avoid giving a precise EBITDA number; instead provide ranges and scenario logic.
  • Trial production timing is not locked: “we haven’t come to a closure… exploring… not yet decided how and when”.

Theme C: Raw material shock (ammonia/sulphur) and margin mechanics

  • Core question(s):
  • Why are costs up so much; are production units running low? How are they managing?
  • How does this affect margins going forward?
  • Management response:
  • States ammonia/sulphur prices have tripled; ammonia ~Rs. 40–42/kg to Rs. 100+; sulphur ~Rs. 30/kg to Rs. 100/kg.
  • Claims they stopped dispatches in the second week of March to avoid selling into unfavorable pricing/acceptability; expects benefit in later months.
  • Margin outlook: says making 8%–10% is not a “great fight”; acknowledges FY26 PAT margin ended at 7.1% partly due to deferred tax/provisions.
  • Strong vs evasive:
  • Strong: provides concrete examples of finished product price increases (e.g., H-acid, vinyl sulphone).
  • Evasive: does not quantify exact margin impact for next two quarters; repeatedly says difficult to predict.

Theme D: Utilisation levels and whether new units will run at expected rates

  • Core question(s):
  • Current utilisation; can it be maintained until raw material situation resolves?
  • Utilisation assumptions for Unit 5/6.
  • Management response:
  • Utilisation stated around 65%–70% (chemicals and fertilisers discussed; chemicals ~65%–70%).
  • For new units: expects 65%–70% utilisation; says they cannot run at 50–55%.
  • Credibility note:
  • Utilisation figures are given with some uncertainty earlier (“I don’t have exact figure… Deepak can you?”) but then confirmed.

Theme E: Tax rate / deferred tax / labour code

  • Core question(s):
  • What tax rate should be assumed going forward? Labour code impact on books?
  • Management response:
  • Normal tax rate guidance: 22–25%, with MAT/carry-forward possibly bringing effective rate to ~18–23% for Pushkar depending on MAT utilisation.
  • Labour code: says no significant impact because gratuity changes not applicable to their permanent employee structure (and contractual 1:1 not present).

Theme F: Bangladesh / Bangladesh elections impact

  • Core question(s):
  • Post-election recovery in Bangladesh; does it affect demand?
  • Management response:
  • Says government is stable post-election, but global energy crisis suppresses demand broadly.
  • Implies Bangladesh impact is temporary; also notes Bangladesh revenue share ~7–8% (from prior call context; reiterated as “business coming from Dhaka”).
  • Evasive element:
  • No quantified recovery timeline; “difficult… give full visibility”.

4. Guidance / Outlook

Explicit guidance (quantitative)

  • FY27 revenue: ~Rs. 1,250–1,300 crores (MD statement).
  • FY27 margin visibility: 8%–10% (PAT/EBITDA margin references vary by question; management repeatedly anchors to ~8% PAT margin).
  • Near-term PAT margin:PAT should be 8%, 8.5%” (Varun/others Q&A).
  • Utilisation: maintain ~65%–70%.
  • Kharif FY27 contribution: “no revenues” expected from Unit 6 and new Unit 5 expansion during Kharif.

Implicit signals (qualitative)

  • Trial production/commercial start is gated by raw material pricing/acceptability, not only electricity readiness:
  • plant almost ready… but… raw material sourcing… perfect pricing… still exploring
  • Conservative stance: management prefers to “wait and watch” to avoid “wrong decision” that could harm long-term business.
  • Margin protection mindset: they stopped dispatches in March to avoid selling at unfavorable economics.

5. Standout Statements (direct / highly revealing)

  • On Kharif revenue impact (clear and strong):
  • Practically this Kharif season we do not expect any revenues from our Unit 6 as well as new expansion of Unit 5.
  • On electricity vs raw material gating:
  • electricity issue has been resolved… but… raw material availabilityperfect pricing… we are still exploring.”
  • On raw material price shock:
  • ammonia and sulphur… prices… almost 3x
  • ammonia used to be Rs. 40–42 a kg, now it is Rs. 100 plus
  • sulphur used to be Rs. 30 a kg, now Rs. 100 a kg
  • On dispatch strategy (inventory/price timing):
  • in the second week of March, we practically stopped our sales… knowingly… prices of raw material are going haywire.”
  • On conservative revenue framing:
  • I am factoring in older volumes and older pricing.
  • there is no point in factoring that” (improved prices) / “practical and conservative call
  • On margin range:
  • making a margin of around 8% to 10%… should not be a great fight
  • On trial readiness but not starting:
  • If we wish, we can start the commencement of the trial production within less than in a month… but… hiccups into the raw material sourcing…”

6. Red Flags / Positive Signals

Red flags
Guidance is scenario-based and repeatedly non-committal (“not yet decided”, “difficult to predict”, “uncertain”).
Kharif revenue explicitly foregone—signals demand/price mismatch and/or inability to pass through costs.
Data/precision issues in answers (MD repeatedly says he’s at the plant and asks CFO to correct figures).
Margin confidence vs reality: FY26 PAT margin ended at 7.1%, yet management maintains 8%–10% expectations—could be optimistic if cost pass-through remains weak.

Positive signals
Balance sheet discipline: net debt metrics are effectively zero/negative (net debt-to-equity -0.01x).
Liquidity buffer: non-lien deposits Rs. 140.68 cr as of Mar’26.
Operational control: deliberate dispatch stoppage suggests active working-capital and pricing management.
Capex funded largely internally; limited leverage for solar term loan.


7. Historical Comparison & Consistency Analysis (vs prior 3 calls provided)

a. Change in Tone Over Time

  • Q2 FY26 (Nov 2025): Optimistic—growth + expansion approvals; electricity delays acknowledged but framed as solvable (“expected… February 2026”).
  • Q3 FY26 (Feb 2026): Still confident—expects electricity connection and trials; margin dip attributed to sulphur cost lag with hope of normalization.
  • Q4 & FY26 (May 2026): More cautious/defensive—explicitly states Kharif season revenue loss and emphasizes inability to predict raw material pricing/acceptability.
  • Classification shift: More Cautious (from “visibility” and “hopefully normalize” to “we are still exploring” and “no revenues in Kharif”).

b. Tracking Past Commitments vs Outcomes

  • Unit 5/6 commissioning/trials timing
  • Past statement (Nov 2025): electricity transformer expected February 2026; trials could begin if electricity comes.
  • Past statement (Feb 2026): still awaiting electricity; hopeful for February.
  • Current (May 2026): electricity resolved early March 2026, but raw material pricing/availability delayed trial/commercial start; no Kharif revenues from Unit 6/new Unit 5 expansion.
  • Result:Delayed (electricity delay + additional gating by raw material economics).
  • FY27 topline visibility
  • Past (Feb 2026): guidance leaned toward ~Rs. 1,500 cr next year (and “should not be any problem”).
  • Current (May 2026): revised conservative ~Rs. 1,250–1,300 cr due to Kharif loss and conservative pricing/volume assumptions.
  • Result:Missed / Downgraded (from 1,500 cr narrative to 1,250–1,300 cr).
  • Margin expectations
  • Past (Nov 2025 / Feb 2026): confidence around 8% PAT margin and improvement toward 10%–11%.
  • Current: maintains 8%–10% but acknowledges FY26 ended at 7.1% and attributes to deferred tax/provisions; near-term PAT guided 8%–8.5%.
  • Result:Partially delivered (FY26 ended below earlier aspirational range).

c. Narrative Shifts

  • From “electricity is the main gating factor” → “raw material pricing/acceptability is the gating factor.”
  • Earlier calls: electricity transformer delay repeatedly emphasized.
  • Current call: electricity resolved, but raw material price tripling and finished product acceptability dominate decisions.
  • From “visibility/normalization” → “conservative buffer / no factoring improved prices.”
  • Current: explicitly says they are not factoring improved prices into FY27 revenue.
  • From expansion optimism → season-by-season revenue sacrifice
  • Current: “foregone Kharif season” is a major shift in revenue narrative.

d. Consistency & Credibility Signals

  • Medium credibility overall:
  • Consistent on balance sheet strength and internal funding.
  • Less consistent on timelines and revenue targets (electricity delays compounded by new gating; FY27 topline reduced).
  • Communication includes hedging and “limited visibility” language more than earlier calls.

e. Evolution of Key Themes

  • Demand/macro: deteriorated narrative—global energy crisis and geopolitical instability now framed as broad-based demand suppression.
  • Margins: moved from “normalization/lag effects” to “cannot predict; acceptability/demand suppressed; stopped sales.”
  • Capex execution: still positive on readiness, but commercialization timing now more uncertain.
  • Renewables: stable positive theme (commissioning continues).

f. Additional Insights (cross-period intelligence)

  • Management’s dispatch stoppage in March suggests they are actively managing working capital and price risk, but it also implies profitability is sensitive to timing and pass-through lag.
  • The explicit statement that they are not factoring improved prices into FY27 revenue indicates either:
  • pricing upside is uncertain/unrealizable, or
  • volume/acceptability constraints prevent capturing the upside—both reduce confidence in upside scenarios.